Drug Makers File With European Medicines Agency For Regulatory Approval Of Investigational Ebola Vaccine; WHO Notes Fluctuating Pattern Of Disease Transmission In DRC Outbreak

CIDRAP News: European regulators consider 2nd Ebola vaccine
“Bavarian Nordic [Thursday] announced that it and its partner Janssen Pharmaceuticals, part of Johnson & Johnson, have submitted an application to the European Medicines Agency (EMA) for approval of their investigational two-dose Ebola vaccine regimen. The news comes as one new Ebola case was reported [Thursday] in the Democratic Republic of the Congo (DRC) outbreak, part of a fluctuating pattern that the World Health Organization (WHO) noted [Thursday] in its weekly snapshot of the event…” (Schnirring, 11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.